Looking to Buy a Home? Do This First
Buying a home is stressful enough without getting blindsided with a higher-than-expected rate on your mortgage — or outright rejection — due to a low credit score or errors on your credit report.
Even so, only half of recent home buyers said they checked their credit report early on in the homebuying process, according to a report released by Experian.
That can make for some nerve-wracked meetings with lenders. About a third of those surveyed said that their credit score surprised them, and a fifth of buyers said their score was lower than expected. Fourteen percent of homebuyers found something negative on their credit report that they didn’t know about.
Related: Why Your Credit Score Is the Most Important Number in Your Life
A low credit score can have costly consequences. A borrower with a FICO score of 760, for example, would pay $1,360 per month on a $300,000 loan, while a borrower with a score of 759 would pay $1,397 per month on the same loan. That difference will add up to more than $10,000 over the life of a 30-year mortgage.
Forty-five percent of future homebuyers surveyed by Experian said that they had delayed purchasing a home in order to work on their credit and qualify for better rates.
If your score is lower than expected, first check the report for errors and contact the credit bureaus about correcting them. If you’ve been dinged for a single missed payment, call your credit card company to see if it will remove the incident from your reports. Then focus on making on-time payments and paying down any high balances to get your debt-to-income ratio below 25 percent.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
